OPTOCIRCUI

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 19, 2021, titled "Press Release".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated Jun 11, 2018, titled "Receives order worth Rs.300 Millions from Philips Health care for various types of sensors.".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 15, 2018, titled "Signing an Agreement with Biosensor Europe SA".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 27, 2018, titled "Launch of next Generation Multilab Vascular System".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 25, 2018, titled "Acquisition of Patents".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 20, 2017, titled "Opto Circuits's wholly owned subsidiary Eurocor GMBH announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen.".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 10, 2017, titled "Opto Circuits's wholly owned subsidiary Eurocor GMBH, announces the completion of the Freeway Stent Study.".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 19, 2016, titled "Opto Circuits and its Subsidiaries receives orders worth Rs.910 Millions from Philips Health Care.".

Opto Circuits (India) Limited has informed the Exchange vide letter dated September 16, 2016 regarding a press release , titled" Opto Circuits's wholly owned subsidiary Eurocor Gmbh, enters the Global Market with their FREEWAY COATED SHUNTBALLOON CATHETER".

Opto Circuits (India) Limited has informed the Exchange vide letter dated July 12, 2016 regarding a press release titled "Opto Circuits' wholly owned subsidiary, Eurocor Gmbh, launches COATED SHUNT BALLOON CATHETER used for DIALYSIS patients which reduces re-intervention and preserves future treatment options".

Opto Circuits (India) Limited has informed the Exchange regarding the press release dated June 08, 2015 titled, "Opto Circuits Group Company-Cardiac Science Corporation Wins Nearly $23 Million, against Zoll in case over wearable defibrillator Technology."

Opto Circuits (India) Limited has informed the Exchange regarding the press release on Audited Finacial Result for the year ended March 31, 2015.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 13, 2015 titled "Opto Circuits Group Company, Cardiac Science, Introduces Powerheart G5 AED to U.S., Canadian Markets".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 6, 2015 titled "Opto Circuits Group Company - Cardiac Science Receives U.S. FDA 510k Clearance to Market New Powerheart G5 AED with CPRD".

Opto Circuits (India) Limited has informed the Exchange vide letter dated January 16, 2015 about Press Release regarding Eurocor GmbH a group company of Opto Circuits (India) Limited has received CE Mark (Communite European) approval for E-Magic Plus Sirolimus Eluting Coronary Stent System.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 20, 2014, titled, "Opto Circuits Group Company - Cardiac Science - Receives U.S. FDA 510 (k) clearance to Market Powerheart G5 AED".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated June 18, 2013 titled "Opto Circuits' group company, Eurocor's partner- Micell Technologies Receives CE Mark Approval for MiStent SES".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 31, 2013 titled "Opto Circuits group company-Eurocor GmbH enters into Licensing Agreement with Biosensors for Drug-eluting Balloon Range".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 01, 2013 titled "Opto Circuits' subsidiary, Cardiac Science, rationalizes its product offering by spinning off its Diagnostic Cardiology product line".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 20, 2012 titled "Unetixs Vascular Inc., an Opto Circuits Group Company Receives CE Certification for Revo 1100".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 10, 2012 titled "Opto Circuits launches its first Sirolimus Drug Eluting Stent".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated June 11, 2012, titled "Opto Circuits launches new Powerheart G5 AED".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 13, 2012, titled "Eurocor GmbH announces presentation of Valentines Trial II results at CRT2012".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 02, 2012, titled "Cardiac Science AEDs now available for Airbus aircraft".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 17, 2012, titled "Opto Circuits' subsidiary Criticare Secures a Contract to Supply nGenuity Vital Signs Monitors to Russian Hospitals".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 04, 2012, titled "Opto Circuits' subsidiary Cardiac Science receives FDA Clearance for MySense Heart".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 13, 2011, titled "500 clubs in Victoria to be equipped with Cardiac Science Powerheart(R) AEDs".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 14, 2011, titled "Opto Circuits' Powerheart(R) AEDs to Combat Sudden Cardiac Arrest at Hong Kong Department of Health".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated July 08, 2011, titled" Opto Circuits' Company Cardiac Science re-enters Japanese market for AEDs with an exclusive sales agreement with Omron Healthcare".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 19, 2011, titled "Eurocor presented 12 months outcome of Spanish Registry at EuroPCR in Paris".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 27, 2011, titled "Opto Circuits' US subsidiary Cardiac Science wins large European AED contract."

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated March 14, 2011, titled "Opto Circuits subsidiary Eurocor's partner Micell Technologies enrolls first patient in randomized trial for MiStent DES, a novel sirolimus-eluting stent system".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated March 03, 2011, titled "Opto Circuits' subsidiary Eurocor announces Study results of Valentines Trial I".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 22, 2011, titled "Opto Circuits' subsidiary, Eurocor, launches MAGICAL (R) in India First ever combinational device angioplasty carried out in India".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 15, 2011, titled "Opto Circuits' subsidiary Eurocor GmbH launches international multi-center registry - Valentines Trail II".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 10, 2011, titled "U.S. Postal Inspection Service Awards AED Contract to Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 08, 2011, titled "Eurocor Steps Up Research Activities".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 02, 2011, titled "Opto Circuits' US subsidiary Cardiac Science awarded Global AED Contract by Tyco Division; Cardiac Science AEDs will protect Tyco facilities worldwide".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 24, 2011, titled "Opto Circuits' US subsidiary Cardiac Science Awarded US Military Certification".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 21, 2011, titled "Opto Circuits subsidiary ready to launch its solutions for treating peripheral arterial disease (PAD) in Germany".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 07, 2011, titled "Opto Circuits' US subsidiary Cardiac Science extends device connectivity to Allscripts Professional (TM) Electronic Health Record".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 10, 2010, titled "Opto Circuits' new subsidiary Cardiac Science Introduces the Next Generation of Burdick ECG Devices".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 06, 2010, titled "Opto Circuits' subsidiary enters Indian market with PTCA combination device - Company gets DCGI registration for "MAGICAL(TM)".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 06, 2010, titled "Opto Circuits Successfully Completes Acquisition of Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 22, 2010, titled "Opto Circuits' subsidiary, Eurocor, launches latest drug-eluting balloon technology FREEWAY, specifically designed for peripheral interventions".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 18, 2010, titled "Criticare Systems Releases Next Generation CO2/N2O Gas Bench."

Opto Circuits (India) Limited has informed the Exchange vide its letter dated October 22, 2010 regarding a press release dated October 21, 2010 titled "Opto Circuits sharpens focus on Emerging Markets".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated October 19, 2010 , titled "Opto Circuits to acquire Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange regarding the press release dated September 27, 2010 titled "Opto Circuits' subsidiary Eurocor's next-gen DEB products gain wide interest amongst United States Interventional cardiologists".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 06, 2010, titled "Opto Circuits' US subsidiary-Criticare Systems Inc.'s new modular patient monitor eVision 9100 recieves US FDA 510 (K) Clearance".